Related links
Twenty years of the Fabry Outcome Survey (FOS)
by M Beck 2022 Cited by 48 The primary aims of the FOS registry are to provide long-term data on the effectiveness and safety of enzyme replacement therapy with agalsidase
Learn more
signaling pathways in cell models of fabry disease nephropathy
by A Labilloy 2015 System, U.S.R.D. USRDS 2014 Annual Data Report: Atlas of End-Stage Renal Disease patients with Fabry disease: findings from the Fabry Registry
Learn more